tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Financial Statements

Compare
0 Followers

Oncolys BioPharma, Inc. Financial Overview

Oncolys BioPharma, Inc.'s market cap is currently ¥82.32B. The company's EPS TTM is ¥-15.37; its P/E ratio is -17.30; Oncolys BioPharma, Inc. is scheduled to report earnings on February 6, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 28.55M¥ 31.38M¥ 63.04M¥ 976.18M¥ 642.49M
Gross Profit¥ 28.30M¥ 31.38M¥ 30.61M¥ 338.49M¥ 198.80M
Operating Income¥ -2.02B¥ -1.68B¥ -1.93B¥ -1.20B¥ -1.45B
EBITDA¥ -2.05B¥ -1.68B¥ -1.93B¥ -1.14B¥ -1.60B
Net Income¥ -2.06B¥ -1.68B¥ -1.94B¥ -1.15B¥ -1.62B
Balance Sheet
Cash & Short-Term Investments¥ 3.72B¥ 2.41B¥ 1.53B¥ 1.71B¥ 3.45B
Total Assets¥ 4.56B¥ 3.20B¥ 2.04B¥ 2.65B¥ 4.29B
Total Debt¥ 320.02M¥ 324.64M¥ 315.17M¥ 393.66M¥ 503.47M
Net Debt¥ -3.35B¥ -1.84B¥ -972.59M¥ -1.07B¥ -2.71B
Total Liabilities¥ 555.91M¥ 446.65M¥ 566.50M¥ 491.69M¥ 697.88M
Stockholders' Equity¥ 4.00B¥ 2.75B¥ 1.47B¥ 2.16B¥ 3.59B
Cash Flow
Free Cash Flow¥ -1.94B¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B
Operating Cash Flow¥ -1.94B¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B
Investing Cash Flow¥ -7.58M¥ -4.71M¥ -5.39M¥ 20.12M¥ -942.00K
Financing Cash Flow¥ 3.22B¥ 2.88B¥ 1.14B¥ -113.83M¥ 3.09B
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

Oncolys BioPharma, Inc. Debt to Assets

Oncolys BioPharma, Inc. Cash Flow

Oncolys BioPharma, Inc. Forecast EPS vs Actual EPS